U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900764) titled 'A Study of CAR-T Cells in Subjects with Systemic Lupus Erythematosus' on March 23.
Brief Summary: The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with SLE.
Study Start Date: April 10
Study Type: INTERVENTIONAL
Condition:
Systemic Lupus Erythematosus (SLE)
Intervention:
DRUG: CAR-T cell
CAR-T cell
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Wuhan Union Hospital, China
Information provided by (Responsible Party): Qiubai Li, Wuhan Union Hospital, China
Published by HT Digital Content Services with permission from Health Daily Digest....